|
1
|
Armani A and Becker RC: The biology,
utilization and attenuation of C-reactive protein in cardiovascular
disease: Part I. Am Heart J. 149:971–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braunwald E: Shattuck lecture -
cardiovascular medicine at the turn of the millennium: Triumphs,
concerns and opportunities. N Engl J Med. 337:1360–1369. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Libbey P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeh ET and Willerson JT: Coming of age of
C-reactive protein: Using inflammation markers in cardiology.
Circulation. 107:370–371. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rifai N and Ridker PM: High sensitive
C-reactive protein: A novel and promising marker of coronary heart
disease. Clin Chem. 47:403–411. 2001.PubMed/NCBI
|
|
6
|
Roberts WL, Moulton L, Law TC, Farrow G,
Cooper-Anderson M, Savory J and Rifai N: Evaluation of nine
automated high sensitive C-reactive protein methods: Implication
for clinical and epidemiological applications. Part 2. Clin Chem.
47:418–425. 2001.PubMed/NCBI
|
|
7
|
Ridker PM, Glynn RJ and Hennekens CH:
C-reactive protein adds to the predictive value of total and HDL
cholesterol in determining risk of first myocardial infarction.
Circulation. 97:2007–2011. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ridker PM, Hennekens CH, Buring JE and
Rifai N: C-reactive protein and other markers of inflammation in
the prediction of cardiovascular disease in women. N Engl J Med.
342:836–843. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thygesen K, Alpert JS, Jaffe AS, Simoons
ML, Chaitman BR and White HD: Joint ESC/ACCF/AHA/WHF Task Force for
the Universal Definition of Myocardial Infarction, Katus HA,
Lindahl B, Morrow DA, et al: Third universal definition of
myocardial infarction. Circulation. 126:2020–2035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elliott M Antman, Marc C, Peter JLMB,
Carolyn HM, Thomas H, Gary P, Branco M, Ramon C, David R and Eugene
B: The TIMI risk score for unstable angina/non–ST elevation MI: a
method for prognostication and therapeutic decision making. JAMA.
284:835–842. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Serruys PW, Morice MC, Kappetein AP,
Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand
M, Bass EJ, et al: Percutaneous coronary intervention versus
coronary-artery bypass grafting for severe coronary artery disease.
N Engl J Med. 360:961–972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Biasucci LM, Liuzzo G, Grillo RL,
Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G
and Maseri A: Elevated levels of C-reactive protein at discharge in
patients with unstable angina predict recurrent instability.
Circulation. 99:855–860. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tracy RP, Lemaitre RN, Psaty BM, Ives DG,
Evans RW, Cushman M, Meilahn EN and Kuller LH: Relationship of
C-reactive protein to risk of cardiovascular disease in the
elderly: Results from the Cardiovascular Health Study and the Rural
Health Promotion Project. Arterioscler Thromb Vasc Biol.
17:1121–1127. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Festa A, D'Agostino R Jr, Howard G,
Mykkänen L, Tracy RP and Haffner SM: Chronic subclinical
inflammation as part of the insulin resistance syndrome: The
insulin resistance atherosclerosis study (IRAS). Circulation.
102:42–47. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fröhlich M, Imhof A, Berg G, Hutchinson
WL, Pepys MB, Boeing H, Muche R, Brenner H and Koenig W:
Association between C-reactive protein and features of the
metabolic syndrome: A population-based study. Diabetes Care.
23:1835–1839. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pickup JC, Mattock MB, Chusney GD and Burt
D: NIDDM as a disease of the innate immune system: Association of
acute-phase reactants and interleukin-6 with metabolic syndrome X.
Diabetologia. 40:1286–1292. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hass E, Yang EH, Gersh BJ and O'Rourke RA:
ST-segment elevation myocardial infarctionHurst's The Heart. Fuster
V, Walsh RA and Harrington RA: 13th. McGraw Hill; New York: pp.
1356–1357. 2011
|
|
19
|
Suleiman M, Khatib R, Agmon Y, Mahamid R,
Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H
and Aronson D: Early inflammation and risk of long-term development
of heart failure and mortality in survivors of acute myocardial
infarction. J Am Coll Cardiol. 47:962–968. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morrow DA, Antman EM, Charlesworth A,
Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH and
Braunwald E: TIMI risk score for ST elevation myocardial
infarction: A convenient, bedside, clinical score for risk
assessment at presentation: An intravenous nPA for treatment of
infarcting myocardium early II trial substudy. Circulation.
102:2031–2037. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Foussas SG, Zairis MN, Lyras AG,
Patsourakos NG, Tsirimpis VG, Katsaros K, Beldekos DJ, Handanis SM,
Mytas DZ, Karidis KS, et al: Early prognostic usefulness of
C-reactive protein added to the Thrombolysis In Myocardial
Infarction risk score in acute coronary syndromes. Am J Cardiol.
96:533–537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schiele F, Meneveau N, Seronde MF, Chopard
R, Descotes-Genon V, Dutheil J and Bassand JP: Reseau de
Cardiologie de Franche Comte: C-reactive protein improves risk
prediction in patients with acute coronary syndromes. Eur Heart J.
31:290–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cristell N, Cianflone D, Durante A,
Ammirati E, Vanuzzo D, Banfi M, Calori G, Latib A, Crea F, Marenzi
G, et al: High-sensitivity C-reactive protein is within normal
levels at the very onset of first ST-segment elevation acute
myocardial infarction in 41% of cases: a multiethnic case-control
study. J Am Coll Cardiol. 58:2654–2661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Casas JP, Shah T, Hingorani AD, Danesh J
and Pepys MB: C-reactive protein and coronary heart disease: A
critical review. J Intern Med. 264:295–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ridker PM, Cushman M, Stampfer MJ, Tracy
RP and Hennekens CH: Inflammation, aspirin and the risk of
cardiovascular disease in apparently healthy men. N Engl J Med.
336:973–979. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sianos G, Morel MA, Kappetein AP, Morice
MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME,
Mohr FW and Serruys PW: The SYNTAX score: An angiographic tool
grading the complexity of coronary artery disease.
EuroIntervention. 1:219–227. 2005.PubMed/NCBI
|
|
27
|
Serruys PW, Onuma Y, Garg S, Sarno G, van
den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T,
et al: Assessment of the SYNTAX score in the Syntax study.
EuroIntervention. 5:50–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
SYNTAX working group, . SYNTAX score
calculator. http://www.syntaxscore.comAccessed November
2009.
|
|
29
|
Zebrack JS, Muhlestein JB, Horne BD and
Anderson JL: Intermountain Heart Collaboration Study Group:
C-reactive protein and angiographic coronary artery disease:
Independent and additive predictors of risk in subjects with
angina. J Am Coll Cardiol. 39:632–637. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tataru MC, Heinrich J, Junker R, Schulte
H, von Eckardstein A, Assmann G and Koehler E: C-reactive protein
and the severity of atherosclerosis in myocardial infarction
patients with stable angina pectoris. Eur Heart J. 21:1000–1008.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arroyo-Espliguero R, Avanzas P,
Cosín-Sales J, Aldama G, Pizzi C and Kaski JC: C-reactive protein
elevation and disease activity in patients with coronary artery
disease. Eur Heart J. 25:401–408. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Azar RR, Aoun G, Fram DB, Waters DD, Wu AH
and Kiernan FJ: Relation of C-reactive protein to extent and
severity of coronary narrowing in patients with stable angina
pectoris or abnormal exercise tests. Am J Cardiol. 86:205–207.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rifai N, Joubran R, Yu H, Asmi M and Jouma
M: Inflammatory markers in men with angiographically documented
coronary heart disease. Clin Chem. 45:1967–1973. 1999.PubMed/NCBI
|
|
34
|
Tanaka A, Shimada K, Sano T, Namba M,
Sakamoto T, Nishida Y, Kawarabayashi T, Fukuda D and Yoshikawa J:
Multiple plaque rupture and C-reactive protein in acute myocardial
infarction. J Am Coll Cardiol. 45:1594–1599. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morrow DA, Rifai N, Antman EM, Weiner DL,
McCabe CH, Cannon CP and Braunwald E: C-reactive protein is a
potent predictor of mortality independently of and in combination
with troponin T in acute coronary syndromes: A TIMI 11A substudy.
Thrombolysis in Myocardial Infarction. J Am Coll Cardiol.
31:1460–1465. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lindahl B, Toss H, Siegbahn A, Venge P and
Wallentin L: FRISC Study Group: Markers of myocardial damage and
inflammation in relation to long-term mortality in unstable
coronary artery disease. Fragmin during instability in coronary
artery disease. N Engl J Med. 343:1139–1147. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mueller C, Buettner HJ, Hodgson JM, Marsch
S, Perruchoud AP, Roskamm H and Neumann FJ: Inflammation and
long-term mortality after non-ST-elevation acute coronary syndrome
treated with a very early invasive strategy in 1042 consecutive
patients. Circulation. 105:1412–1415. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
James SK, Armstong P, Barnathan E, Califf
R, Lindahl B, Siegbahn A, Simoons ML, Topol EJ, Venge P and
Wallentin L: GUSTO-IV-ACS Investigators: Troponin and C-reactive
protein have different relations to subsequent mortality and
myocardial infarction after acute coronary syndrome: A GUSTO-IV
substudy. J Am Coll Cardiol. 41:916–924. 2003. View Article : Google Scholar : PubMed/NCBI
|
